Compare Home Depot Inc (HD) vs Hims and Hers Health Inc (HIMS) Price & Performance

Home Depot (HD) trades at $295.47, up 3.06% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported revenue of $159.51B in 2025, with net income of $14.81B and a net margin of 8.41%. Recent quarterly earnings have consistently beaten expectations, including Q2 2026 EPS of $4.92 versus $4.73 expected. Cash flow from operations remains strong at $19.81B in 2025, though net cash flow was negative due to significant investing outlays. The stock is near its 52-week low, with key support at $282.

The outlook for HD is mixed; strong Pro segment demand and housing tailwinds support long-term growth, but near-term headwinds include weak big-ticket demand and margin pressure. Analyst consensus is bullish with a $379.93 price target, yet rising mortgage rates and competitive pressures pose risks. Investment appeal hinges on execution in a challenging housing market.

Hims & Hers Health trades at $29.54, up 0.24% on the day, with a bullish technical signal from moving averages but mixed earnings performance. Revenue grew to $2.35 billion in 2025, yet the company posted a net loss of $142 million in 2026, reflecting profitability challenges. High valuation ratios like a P/E of 57.14 and negative ROE of -32.03% indicate premium pricing despite weak earnings. Recent news highlights multiple securities class action lawsuits filed in October 2026, creating legal overhangs.

The stock faces headwinds from profitability struggles and legal risks, but analyst consensus remains a Buy with a $32.17 price target, suggesting modest upside. Investment appeal hinges on resolving operational inefficiencies and legal issues to align valuation with fundamentals, while current sentiment is cautious due to recent earnings misses and regulatory scrutiny.